Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.
Allergic rhinitis
Anti-histamines
Corticosteroids
ICT
MASK
Mobile health
Treatment
Journal
Clinical and translational allergy
ISSN: 2045-7022
Titre abrégé: Clin Transl Allergy
Pays: England
ID NLM: 101576043
Informations de publication
Date de publication:
09 Dec 2020
09 Dec 2020
Historique:
received:
01
03
2020
accepted:
25
08
2020
entrez:
10
12
2020
pubmed:
11
12
2020
medline:
11
12
2020
Statut:
epublish
Résumé
The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users. The Allergy Diary-MASK-air-mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis. 9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines. This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
Sections du résumé
BACKGROUND
BACKGROUND
The analysis of mobile health (mHealth) data has generated innovative insights into improving allergic rhinitis control, but additive information is needed. A cross-sectional real-world observational study was undertaken in 17 European countries during and outside the estimated pollen season. The aim was to collect novel information including the phenotypic characteristics of the users.
METHODS
METHODS
The Allergy Diary-MASK-air-mobile phone app, freely available via Google Play and App, was used to collect the data of daily visual analogue scales (VASs) for overall allergic symptoms and medication use. Fluticasone Furoate (FF), Mometasone Furoate (MF), Azelastine Fluticasone Proprionate combination (MPAzeFlu) and eight oral H1-antihistamines were studied. Phenotypic characteristics were recorded at entry. The ARIA severity score was derived from entry data. This was an a priori planned analysis.
RESULTS
RESULTS
9037 users filled in 70,286 days of VAS in 2016, 2017 and 2018. The ARIA severity score was lower outside than during the pollen season. Severity was similar for all treatment groups during the pollen season, and lower in the MPAzeFlu group outside the pollen season. Days with MPAzeFlu had lower VAS levels and a higher frequency of monotherapy than the other treatments during the season. Outside the season, days with MPAzeFlu also had a higher frequency of monotherapy. The number of reported days was significantly higher with MPAzeFlu during and outside the season than with MF, FF or oral H1-antihistamines.
CONCLUSIONS
CONCLUSIONS
This study shows that the overall efficacy of treatments is similar during and outside the pollen season and indicates that medications are similarly effective during the year.
Identifiants
pubmed: 33298191
doi: 10.1186/s13601-020-00342-x
pii: 10.1186/s13601-020-00342-x
pmc: PMC7726888
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
62Commentaires et corrections
Type : ErratumIn
Références
Allergy Asthma Proc. 2016 Sep;37(5):103-11
pubmed: 27657517
Clin Transl Allergy. 2019 Mar 11;9:16
pubmed: 30911372
Adv Chronic Kidney Dis. 2019 Mar;26(2):99-109
pubmed: 31023454
Ann Intern Med. 2017 Dec 19;167(12):876-881
pubmed: 29181536
Allergy. 2017 Jun;72(6):857-865
pubmed: 28072463
Clin Exp Allergy. 2017 Dec;47(12):1526-1533
pubmed: 28886234
Int Arch Allergy Immunol. 2018;176(3-4):181-188
pubmed: 29742519
Allergy. 2017 Aug;72(8):1261-1266
pubmed: 28140507
Int Arch Allergy Immunol. 2019;178(4):363-369
pubmed: 30759448
J Allergy Clin Immunol. 2019 Mar;143(3):864-879
pubmed: 30273709
Bull World Health Organ. 1995;73(3):275-9
pubmed: 7614659
J Allergy Clin Immunol. 2017 Sep;140(3):891-893.e7
pubmed: 28579375
Clin Transl Allergy. 2018 Oct 25;8:45
pubmed: 30386555
Clin Transl Allergy. 2019 Jan 28;9:7
pubmed: 30705747
Allergy. 2019 Apr;74(4):698-708
pubmed: 30447164
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
J Med Internet Res. 2020 Aug 10;22(8):e19611
pubmed: 32530816
J Allergy Clin Immunol Pract. 2020 Mar;8(3):1063-1073.e4
pubmed: 31786252
Chin Med J (Engl). 2020 Jul 5;133(13):1561-1567
pubmed: 32649522
Allergy. 2005 Mar;60(3):350-3
pubmed: 15679721
Pulmonology. 2020 Jun 23;:
pubmed: 32636165
BMC Immunol. 2013 Nov 05;14:49
pubmed: 24188324
Allergy. 2018 Feb;73(2):505-510
pubmed: 28906011
Ann Allergy Asthma Immunol. 2010 Aug;105(2):168-73
pubmed: 20674829
Clin Transl Allergy. 2019 Sep 9;9:44
pubmed: 31516692
Clin Transl Allergy. 2018 Sep 17;8:36
pubmed: 30237869
J Allergy Clin Immunol. 2020 Jan;145(1):70-80.e3
pubmed: 31627910
J Allergy Clin Immunol. 2006 Jan;117(1):158-62
pubmed: 16387600
J Investig Allergol Clin Immunol. 2018;28(1):42-44
pubmed: 28906252
Allergy. 2020 Jul;75(7):1672-1688
pubmed: 31995656
Clin Exp Allergy. 2005 Jun;35(6):728-32
pubmed: 15969662
Clin Transl Allergy. 2018 Jul 9;8:23
pubmed: 30002811
J Allergy Clin Immunol. 2019 Jul;144(1):135-143.e6
pubmed: 30951790
Allergy. 2019 Oct;74(10):1910-1919
pubmed: 30942904
World Allergy Organ J. 2018 Jul 16;11(1):15
pubmed: 30061979
Clin Exp Allergy. 2019 Apr;49(4):442-460
pubmed: 30597673
Allergy. 2018 Sep;73(9):1763-1774
pubmed: 29336067